NDC11 57894051401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 57894-0514-01 | 57894-0514 |
| 57894-0514-1 | 57894-0514 |
| 57894-514-01 | 57894-514 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rybrevant Faspro | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | Janssen Biotech, Inc. | 9e58b045-e352-4f62-99bf-77fae1bebc69 | 2026-06-17 | Warnings, Adverse reactions | 57894-514-01 57894-514 57894051401 |